Operationalizing Biosimilars in Specialty Pharmacies

EP: 1.Comparing Biologics and Biosimilars

EP: 2.Biosimilar Utilization and Inventory Management

Now Viewing

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

EP: 5.Key Factors to Consider when Switching to Biosimilars

EP: 6.Pharmacy and Provider Collaboration

EP: 7.Biosimilar Copay Programs

Video content above is prompted by the following:

• What does the current process look like for switching between reference products and biosimilars and between biosimilars at specialty pharmacies, and how can it be streamlined?
• In states that allow pharmacists to switch to a biosimilar without prior prescriber approval, how effective are automatic substitutions based on interchangeability and collaborative practice agreements?